The carcinogenic roles of ROS include genetic alterations, cell proliferation through the PI3K/AKT/mTOR and MAPK/ERK pathways, and promotion of the epithelial–mesenchymal transition, whereas their tumor-suppressive roles include apoptosis, necroptosis, and ferroptosis [22]. The gene discussed is MTOR; the disease is neoplasm.